Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Deubiquitinase (DUB)‐mediated cleavage of ubiquitin chain balances ubiquitination and deubiquitination for determining protein fate. USP7 is one of the best characterized DUBs and functionally important. Numerous proteins have been identified as potential substrates and binding partners of USP7; those play crucial roles in diverse array of cellular and biological processes including tumour suppression, cell cycle, DNA repair, chromatin remodelling, and epigenetic regulation. This review aims at summarizing the current knowledge of this wide association of USP7 with many cellular processes that enlightens the possibility of abnormal USP7 activity in promoting oncogenesis and the importance of identification of specific inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748 · cited 1×
“The tumour suppressor phosphatase and tensin homologue (PTEN) is frequently mutated, deleted, or silenced in many types of human cancers.(86) Monoubiquitination and subsequent translocation to nucleus are important for PTEN function.”
BackgroundChauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589 · cited 1×
“P5091 induces apoptosis in bortezomib resistant multiple myeloma cells.(109) Clinical trials using P5091 in combination with HDAC inhibitor vorinostat (SAHA), lenalidomide, or dexamethasone have demonstrated the synergistic effect on multiple myeloma.”
BackgroundThe deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Turnbull, A. P., Ioannidis, S., Krajewski, W. W., Pinto-Fernandez, A., Heride, C., Martin, A. C. L., Tonkin, L. M., Townsend, E. C., Buker, S. M., Lancia, D. R., et al. (2017) · Nature · doi:10.1038/nature24451 · Cited by 463 · cited 4×
“One study has shown that overexpression of USP7 prevents UVR‐induced RNF168 degradation and ectopic expression of RNF168 prevents the formation of UVR‐induced foci (UVRIF) and ionizing radiation‐induced foci (IRIF) of polyubiquitinated H2A.19,63 Studies have found USP7 to be the specific deubiquitinase for H2B in vitr…”
BackgroundInfluentialDisruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379 · cited 5×
“Again, knockdown of USP7 results in P53 upregulation with cell cycle arrest.78 In case of breast cancer, TSPYL5 physically interacts with USP7 and blocks the interaction between P53 and USP7 leading to reduced activity of USP7 towards P53 and finally inhibition of activation of P53‐targeted genes.81 Reduction of USP7…”
BackgroundInfluentialUSP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333 · cited 1×
“Both compounds can non‐covalently target and selectively inhibit USP7 relative to 36 other deubiquitinases and induce cell death with significant impact on cellular USP7, MDM2, and p53 signalling pathways.(112,113) Recently a new class of”
BackgroundMolecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C. H., & Frappier, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1067 · Cited by 315
Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., Harpon, J., Battaglia, V., Vivat, V., Sippl, W., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.007 · Cited by 270 · cited 1×
“A high‐throughput screening method was performed to find a structurally distinct molecule, and a structural class of small molecules represented by HBX 19,818 and HBX 28,258 was discovered.(103) These compounds inhibit USP7 activity with IC50 of 28.”
MethodMailand, N., Bekker-Jensen, S., Bartek, J., & Lukas, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.016 · Cited by 258
Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., & Shi, Y. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040027 · Cited by 251
Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303977200 · Cited by 228
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
Wang, Q., Ma, S., Song, N., Li, X., Liu, L., Yang, S., Ding, X., Shan, L., Zhou, X., Su, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85747 · Cited by 206
Zhang, X., Horibata, K., Saijo, M., Ishigami, C., Ukai, A., Kanno, S.-I., Tahara, H., Neilan, E. G., Honma, M., Nohmi, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2228 · Cited by 201 · cited 15×
“One of the derivatives C7 might bind to the ubiquitin‐binding pocket of the catalytic domain of USP7 and inhibit the binding of ubiquitin to USP7.”
BackgroundInfluentialStructure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.
Lamberto, I., Liu, X., Seo, H.-S., Schauer, N. J., Iacob, R. E., Hu, W., Das, D., Mikhailova, T., Weisberg, E. L., Engen, J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.003 · Cited by 192 · cited 1×
“It acts as a probe for USP7 with IC50 of 90 nM.(111) Several other studies have been carried out based on structural features of USP7 catalytic site.”
BackgroundSelective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47.
Weinstock, J., Wu, J., Cao, P., Kingsbury, W. D., McDermott, J. L., Kodrasov, M. P., McKelvey, D. M., Suresh Kumar, K. G., Goldenberg, S. J., Mattern, M. R., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200276j · Cited by 187
Inactivation of HAUSP in vivo modulates p53 function.
Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W. (2010) · Oncogene · doi:10.1038/onc.2009.427 · Cited by 176
TSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Epping, M. T., Meijer, L. A. T., Krijgsman, O., Bos, J. L., Pandolfi, P. P., & Bernards, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2142 · Cited by 117
USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin
Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J., & Mailand, N. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200807137 · Cited by 113 · cited 2×
“Claspin is destabilized by E3 ligase SCFβTrcp (Skp, Cullin, and F‐boxβTrCP) and APC (anaphase‐promoting complex), and interestingly USP7 is found to oppose the SCF‐mediated degradation of claspin.(37,69) USP7 also controls CHK1 stability directly.”
BackgroundPozhidaeva, A., Valles, G., Wang, F., Wu, J., Sterner, D. E., Nguyen, P., Weinstock, J., Kumar, K. G. S., Kanyo, J., Wright, D., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.004 · Cited by 107 · cited 16×
“One of the derivatives C7 might bind to the ubiquitin‐binding pocket of the catalytic domain of USP7 and inhibit the binding of ubiquitin to USP7.”
BackgroundInfluentialUSP7 controls Chk1 protein stability by direct deubiquitination.
Alonso-de Vega, I., Martín, Y., & Smits, V. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973324 · Cited by 92 · cited 1×
“USP7 also controls CHK1 stability directly.(22) Depletion or inhibition of USP7 lowers CHK1 levels, but this effect of USP7 on CHK1 is claspin independent.”
BackgroundDi Lello, P., Pastor, R., Murray, J. M., Blake, R. A., Cohen, F., Crawford, T. D., Drobnick, J., Drummond, J., Kategaya, L., Kleinheinz, T., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01293 · Cited by 90 · cited 1×
“Both compounds can non‐covalently target and selectively inhibit USP7 relative to 36 other deubiquitinases and induce cell death with significant impact on cellular USP7, MDM2, and p53 signalling pathways.(112,113) Recently a new class of”
BackgroundUSP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168.
Zhu, Q., Sharma, N., He, J., Wani, G., & Wani, A. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1007785 · Cited by 87 · cited 2×
“One study has shown that overexpression of USP7 prevents UVR‐induced RNF168 degradation and ectopic expression of RNF168 prevents the formation of UVR‐induced foci (UVRIF) and ionizing radiation‐induced foci (IRIF) of polyubiquitinated H2A.(19,63) Studies have found USP7 to be the specific deubiquitinase for H2B in vi…”
BackgroundDeubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83
USP7 is essential for maintaining Rad18 stability and DNA damage tolerance.
Zlatanou, A., Sabbioneda, S., Miller, E. S., Greenwalt, A., Aggathanggelou, A., Maurice, M. M., Lehmann, A. R., Stankovic, T., Reverdy, C., Colland, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.149 · Cited by 77
Tian, X., Isamiddinova, N. S., Peroutka, R. J., Goldenberg, S. J., Mattern, M. R., Nicholson, B., & Leach, C. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0317 · Cited by 76
Agathanggelou, A., Smith, E., Davies, N. J., Kwok, M., Zlatanou, A., Oldreive, C. E., Mao, J., Da Costa, D., Yadollahi, S., Perry, T., et al. (2017) · Blood · doi:10.1182/blood-2016-12-758219 · Cited by 75 · cited 1×
“It is proposed that USP7 can be targeted for treatment of haematological malignancies with DDR defects.(50) In case of CLL, USP7 inhibition prevents homologous recombination repair (HRR) and prompts cell death independently of ATM and p53.”
BackgroundZhang, C., Lu, J., Zhang, Q.-W., Zhao, W., Guo, J.-H., Liu, S.-L., Wu, Y.-L., Jiang, B., & Gao, F.-H. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.025 · Cited by 67 · cited 15×
“One of the derivatives C7 might bind to the ubiquitin‐binding pocket of the catalytic domain of USP7 and inhibit the binding of ubiquitin to USP7.”
BackgroundInfluentialHernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M., & Freire, R. (2017) · Oncogene · doi:10.1038/onc.2017.21 · Cited by 61 · cited 1×
“Lack of Geminin can cause re‐replication events ultimately leading to genome instability.(76) It is proposed that USP7 can be targeted for treatment of haematological malignancies with DDR defects.”
BackgroundUSP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability.
Qian, J., Pentz, K., Zhu, Q., Wang, Q., He, J., Srivastava, A. K., & Wani, A. A. (2015) · Oncogene · doi:10.1038/onc.2014.394 · Cited by 61
Mungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54 · cited 2×
“In stress condition, P53 is activated that increases MDM2 accumulation which in turn triggers SUV39H1 degradation and hence relieves the repressive effect of H3K9me3.(85) Dysregulated MDM2 state can be targeted for drug therapy by disrupting its association with USP7 and thus inhibiting MDM2‐mediated degradation of P5…”
BackgroundBRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.
Biswas, K., Philip, S., Yadav, A., Martin, B. K., Burkett, S., Singh, V., Babbar, A., North, S. L., Chang, S., & Sharan, S. K. (2018) · Nature Communications · doi:10.1038/s41467-018-03020-6 · Cited by 41 · cited 1×
“USP7 through Brain and Reproductive organ Expressed regulates another protein CDC25A (cell division cycle A) which is phosphorylated after DNA damage in a CHK1‐dependent manner.(71)”
BackgroundUSP7 regulates the stability and function of HLTF through deubiquitination.
Qing, P., Han, L., Bin, L., Yan, L., & Ping, W. X. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23317 · Cited by 35 · cited 1×
“USP7‐mediated deubiquitination is found to prolong the half‐life of Human helicase‐like transcription factor (HLTF) in stress condition, which in turn increases PCNA polyubiquitination.(25) USP7 is also a critical regulator of Rad18 protein level.”
BackgroundSarasin, A. (2012) · Genome Medicine · doi:10.1186/gm343 · Cited by 34 · cited 1×
“After DNA lesion, the interaction of RNA polymerase II with UVSSA and USP7 recruits several other factors at the stalled site.(30) This complex stabilizes CSB that is required for arranging TC‐NER complex and remodelling RNA polymerase II action.”
BackgroundUSP7 protects genomic stability by regulating Bub3.
Giovinazzi, S., Sirleto, P., Aksenova, V., Morozov, V. M., Zori, R., Reinhold, W. C., & Ishov, A. M. (2014) · Oncotarget · doi:10.18632/oncotarget.1989 · Cited by 34
Cited by
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Schauer, N. J., Liu, X., Magin, R. S., Doherty, L. M., Chan, W. C., Ficarro, S. B., Hu, W., Roberts, R. M., Iacob, R. E., Stolte, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62076-x · Cited by 125
Peng, Y., Liu, Y., Gao, Y., Yuan, B., Qi, X., Fu, Y., Zhu, Q., Cao, T., Zhang, S., Yin, L., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1457-8 · Cited by 54
Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1
Liang, L., Peng, Y., Zhang, J., Zhang, Y., Roy, M., Han, X., Xiao, X., Sun, S., Liu, H., Nie, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.206227 · Cited by 37
“Truncation mutants of GFP-USP7 and Flag-GATA1 were co-transfected into HEK293T cells and co-immunoprecipitation analyses revealed that the N-terminal TRAF-like domain (1-208) of USP7 was critical for the interaction between GATA1 and USP7 (Figure 4D).”
Background
Metadata
- Authors
- Yeasmin Khusbu, F., Chen, F., & Chen, H.
- Venue
- Cell Biochemistry and Function
- Publisher
- Wiley
- Published
- 2018-05-20
- Volume
- 36
- Issue
- 5
- Pages
- 244-254
- ISSN
- 0263-6484 (ISSN-L)
- 1099-0844
- OpenAlex
- W2804958390
- Cited by
- 36
- References
- 35
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.